Presentation highlights include 48-month data from the OAKS and DERBY trials as well as the GALE open-label extension.

The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and ...

The tool is designed to help with the application of mono-dose, dry eye eyedrop vials more easily and accurately.

KAIST developed a microbial strain for efficient lutein production, offering an eco-friendly alternative to traditional ...

Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...